Stegall v. Ohio State Medical Board

635 N.E.2d 1291, 92 Ohio App. 3d 389, 1993 Ohio App. LEXIS 5804
CourtOhio Court of Appeals
DecidedDecember 2, 1993
DocketNo. 93AP-211.
StatusPublished

This text of 635 N.E.2d 1291 (Stegall v. Ohio State Medical Board) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stegall v. Ohio State Medical Board, 635 N.E.2d 1291, 92 Ohio App. 3d 389, 1993 Ohio App. LEXIS 5804 (Ohio Ct. App. 1993).

Opinion

Strausbaugh, Judge.

Appellant, Victor J. Stegall, M.D., appeals the decision of the Franklin County Court of Common Pleas upholding the order of the State Medical Board (“board”) to indefinitely suspend Dr. Stegall’s medical license. Appellant raises the following three assignments of error:

*391 “1. O.A.C. 4731-11-04 is unreasonable and without basis in medical science; the common pleas court thus abused its discretion in upholding a license suspension based on an alleged violation of the rule.
“2. The common pleas court abused its discretion in upholding the order of the medical board in the complete absence of rehable, probative and substantial evidence in support of the board’s conclusions and order.
“3. The lower court abused its discretion in affirming the medical board’s order since the board improperly placed the burden of proof upon Dr. Stegall.”

The board commenced action against appellant by citation letter dated May 8, 1991. In the letter, the board notified appellant that it proposed to take disciplinary action against his license on the grounds that his prescribing of controlled substances for weight loss to ten patients violated the board rule concerning the utilization of such substances. Ohio Adm.Code 4731-11-04. Specifically, the board charged that in his prescribing of controlled substances for weight loss to these ten patients, appellant failed to use the controlled substances as an adjunct in the treatment of obesity, failed to prescribe the drugs for a period limited to fourteen days, failed to weigh the patients every fourteen days, failed to discontinue the controlled substances when the patients did not lose weight and failed to follow the Food and Drug Administration (“FDA”) approved labeling for these drugs. Therefore, the board charged that Dr. Stegall was in violation of Ohio Adm.Code 4731-11-04, and so was in violation of R.C. 4731.-22(B)(20), which allows the board to take disciplinary action against a licensee for directly or indirectly violating, attempting to violate, or assisting in the violation of a rule duly adopted by the board. Further, the citation letter notified appellant that the board proposed to deem this same conduct violations of R.C. 4731.22(B)(2) (“[fjailure to use reasonable care discrimination in the administration of drugs * * *”); R.C. 4731.22(B)(3) (“[sjelling, prescribing, giving away, or administering drugs for other than legal and legitimate therapeutic purposes * * *”); and R.C. 4731.22(B)(6) (“[a] departure from, or the failure to conform to, minimal standards of care of similar practitioners under the same or similar circumstances, whether or not actual injury to a patient is established”) in accordance with Ohio Adm.Code 4731-11-04(C).

Appellant received a hearing before an attorney hearing examiner. The hearing examiner’s report concluded that appellant had violated the following: (1) R.C. 4731.22(B)(2), failure to use reasonable care discrimination in the administration of drugs; (2) R.C. 4731.22(B)(3), selling, prescribing, giving away or administering drugs for other than legal and legitimate therapeutic purposes; (3) R.C. 4731.22(B)(6), departure from, or failure to conform to minimal standards of care of similar practitioners under the same or similar circumstances, whether or not actual injury to a patient is established; and (4) R.C. 4731.22(B)(20), failure to *392 comply with a rule of the board. Appellant filed objections to the report. However, the board voted to approve and confirm the hearing examiner’s proposed findings of fact and conclusions of law, and to adopt the recommended order.

Appellant filed an appeal to the Franklin County Court of Common Pleas. The referee issued his report on September 23, 1992, finding that the board’s order was supported by reliable, probative and substantial evidence. The referee further found that Ohio Adm.Code Chapter 4731-11 was properly promulgated and adopted by the board pursuant to R.C. Chapter 119, and that pursuant to the Supreme Court’s decision in In re Williams (1991), 60 Ohio St.3d 85, 573 N.E.2d 638, the board was not required to provide expert testimony in support of its charges that appellant had violated specific provisions of the administrative rules. Therefore, the referee recommended that the decision of the board be affirmed. The common pleas court agreed with the referee’s conclusions, and adopted the report. Appellant now appeals to this court.

It should be noted initially that the court of common pleas has the duty to affirm an order of the board where the order is supported by reliable, probative and substantial evidence. R.C. 119.12; Univ. of Cincinnati v. Conrad (1980), 63 Ohio St.2d 108, 17 O.O.3d 65, 407 N.E.2d 1265. Consequently, this court is limited to determining whether there was an abuse of discretion by the common pleas court. Asad v. Ohio State Med. Bd. (1992), 79 Ohio App.3d 143, 606 N.E.2d 1064.

By his first assignment of error, appellant contends that Ohio Adm.Code 4731-11-04 is unreasonable and without basis in medical science and, therefore, the lower court abused its discretion in upholding his license suspension in violation of this rule. Further, appellant argues that the requirements and restrictions set forth in Ohio Adm.Code 4731-11-04 bear no rational relationship to the clinical practice of medicine and that the promulgation of such rule is outside the medical board’s legal authority.

The rule itself is clear and unambiguous. Physicians are instructed that they shall not utilize a Schedule III or Schedule IV controlled substance for the purposes of weight reduction unless the drug has an FDA-approved indication for this purpose and then only in accordance with all of the other provisions of the rule. The specific requirements are then set forth in subdivision (B) of the rule. That subdivision states that a physician may utilize a Schedule III or IV controlled substance for the purpose of weight reduction in the treatment of obesity only as an adjunct, in accordance with the FDA-approved labeling for the product, and in a regimen of weight reduction which is based on caloric *393 restriction. Additionally, the rule provides that the following five conditions be met:

“(1) Before initiating treatment utilizing a schedule III or IV controlled substance, the physician determines through review of his own records of prior treatment, or through review of the records of prior treatment which another treating physician or weight-loss program has provided to the physician, that the patient has made a substantial good-faith effort to lose weight in a treatment program utilizing a regimen of weight reduction based on caloric restriction, nutritional counseling, behavior modification, and exercise, without the utilization of controlled substances, and that said treatment has been ineffective.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Asad v. Ohio State Med. Bd.
606 N.E.2d 1064 (Ohio Court of Appeals, 1992)
Arlen v. State
399 N.E.2d 1251 (Ohio Supreme Court, 1980)
University of Cincinnati v. Conrad
407 N.E.2d 1265 (Ohio Supreme Court, 1980)
In re Williams
573 N.E.2d 638 (Ohio Supreme Court, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
635 N.E.2d 1291, 92 Ohio App. 3d 389, 1993 Ohio App. LEXIS 5804, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stegall-v-ohio-state-medical-board-ohioctapp-1993.